Page last updated: 2024-09-03

sf 6,5 and Disease Exacerbation

sf 6,5 has been researched along with Disease Exacerbation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aeed, H; Barg, J; Bruck, R; Halpern, Z; Hershkoviz, R; Lider, O; Matas, Z; Zaidel, L1
Aeed, H; Bruck, R; Halpern, Z; Hershkoviz, R; Lider, O; Shirin, H1

Reviews

1 review(s) available for sf 6,5 and Disease Exacerbation

ArticleYear
Non-peptidic analogs of the cell adhesion motif RGD prevent experimental liver injury.
    The Israel Medical Association journal : IMAJ, 2000, Volume: 2 Suppl

    Topics: Animals; Carcinogens; Concanavalin A; Disease Progression; Guanidines; Hepatitis, Autoimmune; Liver Cirrhosis, Experimental; Mice; Mitogens; Oligopeptides; Rats; Receptors, Immunologic; T-Lymphocytes; Thioacetamide; Transaminases; Tumor Necrosis Factor-alpha; Valerates

2000

Other Studies

1 other study(ies) available for sf 6,5 and Disease Exacerbation

ArticleYear
Inhibition of experimentally-induced liver cirrhosis in rats by a nonpeptidic mimetic of the extracellular matrix-associated Arg-Gly-Asp epitope.
    Journal of hepatology, 1996, Volume: 24, Issue:6

    Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Biopsy; Carcinogens; Cell Adhesion; Disease Progression; Extracellular Matrix; Female; Fibronectins; Guanidines; Hemodynamics; Hypertension, Portal; Liver; Liver Cirrhosis, Experimental; Oligopeptides; Rats; Rats, Wistar; Spleen; Thioacetamide; Valerates

1996